|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.270 USD | +1.54% |
|
+0.69% | -17.57% |
| Capitalization | 430M 364M 335M 317M 587M 39.76B 598M 3.92B 1.54B 19.27B 1.61B 1.58B 67.93B | P/E ratio 2026 * |
-3.26x | P/E ratio 2027 * | -9.34x |
|---|---|---|---|---|---|
| Enterprise value | 257M 217M 200M 189M 351M 23.73B 357M 2.34B 918M 11.51B 962M 942M 40.55B | EV / Sales 2026 * |
1x | EV / Sales 2027 * | 0.76x |
| Free-Float |
96.85% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vanda Pharmaceuticals Inc.
| 1 day | +1.54% | ||
| 1 week | +0.69% | ||
| Current month | +5.21% | ||
| 1 month | -15.17% | ||
| 3 months | -2.68% | ||
| 6 months | +37.95% | ||
| Current year | -17.57% |
| 1 week | 7.02 |  | 7.42 |
| 1 month | 6.57 | | 7.79 |
| Current year | 5.73 | | 9.94 |
| 1 year | 3.81 | | 9.94 |
| 3 years | 3.3 | | 9.94 |
| 5 years | 3.3 | | 21.86 |
| 10 years | 3.3 | | 33.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 30/04/2003 | |
Kevin Moran
DFI | Director of Finance/CFO | 42 | 14/03/2020 |
Scott Howell
HRO | Human Resources Officer | - | 31/07/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 31/05/2021 | |
Richard Dugan
BRD | Director/Board Member | 84 | 30/11/2005 |
Phaedra Chrousos
BRD | Director/Board Member | 46 | 23/04/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.54% | +0.69% | +67.90% | +15.76% | 430M | |
| -0.50% | +5.52% | +36.60% | +106.00% | 52.7B | |
| -5.93% | -6.53% | +88.06% | +25.24% | 44.07B | |
| +1.18% | -6.67% | +98.87% | +707.15% | 31.19B | |
| +0.78% | +7.77% | +4.21% | -15.49% | 26.03B | |
| +2.99% | +27.86% | +2.19% | +1,452.47% | 19.5B | |
| -0.39% | +0.85% | +65.10% | -31.77% | 18.88B | |
| -2.72% | +6.60% | +66.18% | +239.26% | 17.76B | |
| -1.69% | -0.70% | +37.37% | -35.86% | 17.49B | |
| -2.69% | +3.86% | +68.67% | - | 15.49B | |
| Average | -1.12% | +4.39% | +53.51% | +273.64% | 24.35B | |
| Weighted average by Cap. | -1.53% | +3.30% | +54.19% | +261.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 257M 218M 200M 190M 352M 23.8B 358M 2.35B 921M 11.54B 965M 945M 40.66B | 354M 300M 276M 261M 484M 32.78B 493M 3.23B 1.27B 15.89B 1.33B 1.3B 56B |
| Net income | -133M -113M -104M -98.45M -182M -12.35B -186M -1.22B -478M -5.99B -501M -490M -21.1B | -54.79M -46.41M -42.7M -40.41M -74.9M -5.07B -76.21M -500M -196M -2.46B -206M -201M -8.66B |
| Net Debt | -173M -147M -135M -128M -237M -16.03B -241M -1.58B -620M -7.77B -650M -636M -27.38B | -161M -136M -126M -119M -220M -14.9B -224M -1.47B -577M -7.22B -604M -592M -25.46B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/04/26 | 7.270 $ | +1.54% | 1,062,614 |
| 16/04/26 | 7.160 $ | -1.51% | 861,956 |
| 15/04/26 | 7.270 $ | -0.68% | 862,203 |
| 14/04/26 | 7.320 $ | +2.23% | 1,123,152 |
| 13/04/26 | 7.160 $ | -0.83% | 1,016,717 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VNDA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition